PERIGON Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1312 participants.

Also called NCT02088554

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,312 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02088554
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, France, Germany, Italy, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02088554. Allocation not applicable; no masking; primary purpose treatment. Start 2014-05-12 (actual); primary completion 2023-04-17 (actual). Results posted on 2024-06-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PERIGON Pivotal Trial
Acronym
PERIGON
Condition
Aortic Stenosis
Intervention (Device)
Model 400 aortic valve bioprosthesis
Lead sponsor
Medtronic Cardiac Surgery (class: industry)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct02088554
Content hash
d70e431f8eb27b1392ce06244888bf4b1aa91050e40a9c4ae8092e563d0aa8f3